On Demand Webinar: Accelerating the Development of a Virus-Like-Particle Vaccine against COVID-19
Insights from a Global Collaboration Accelerating Vaccine Development with an Optimized VLP Platform
The COVID-19 pandemic further emphasized the need for collaboration in the development of urgently needed vaccines and therapeutics. In this webinar, we take you behind the scenes of our collaboration with TechnoVax and Innovative Biotech in which a scalable VLP vaccine platform was optimized or use in a production facility in Nigeria in response to the need for local production of SARS-CoV-2 vaccines. The flexibility and robustness of the platform will enable its rapid deployment to support the West African pandemic readiness program. Initial development of the VLP process began in late 2019 and by March 2020, was already adapted for production of a SARS-CoV-2 vaccine.
In this presentation we will explore:
- About building a priceless collaborative network with integrated solutions
- Virus-Like Particle Vaccines
- Process Development Overview and Challenges
- Pre-clinical Results and Next Steps
Register Now:
Webinar Accelerating the Development of a VLP Vaccine against Covid-19
